불임 치료 서비스 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 제공업체별, 지역별, 부문별 예측(2024-2030년)

Fertility Services Market Growth & Trends:

The global fertility services market is anticipated to reach USD 70.27 billion by 2030 and is projected to grow at a CAGR of 7.50% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising adoption of fertility services, especially among individuals facing issues such as old age, premature ovarian failure, and rising infertility in male and female, is a major driver propelling market growth.

IVF services are particularly popular among individuals aged between 35 and 39 years, driving demand for fertility services. Furthermore, the global fertility rate is falling steadily due to several issues, including the growing trend of delayed marriages and the increasing incidence of age-related infertility. According to the UN's World Family Planning 2022 report, the global fertility rate decreased from 3.3 children per woman in 1990 to 2.3 in 2021. This decreasing fertility rate has significantly increased the demand for male and female ART. In addition, supportive government funding for expensive ART procedures is expected to drive market growth.

In India, the government offers incentives, such as low-interest loans to establish hospitals, subsidies to buy medicines & equipment, and buying lands for clinics. To capitalize on low costs, the Indian government issues M (medical) visas to foreign tourists and MX visas for spouses, valid for a year. For instance, in May 2022, in Australia, under NSW Government 2022-2023 budget, women in New South Wales opting for IVF will be provided with a USD 2,000 cash rebate to reduce the treatment costs for patients. The demand for frozen nondonor IVF treatment is projected to increase significantly. This can be attributed to the large number of procedures performed using frozen nondonor (patient's eggs).

Fertility Services Market Report Highlights:

• Based on type, the treatment segment held the market with the largest revenue share of 65.33% in 2023. The treatment segment is further segmented into In-vitro fertilization (IVF) and artificial insemination. In 2023, IVF treatment dominated the market growth
• Improved outcomes of infertility treatments has led to positive awareness regarding fertility services. Favorable reimbursement policies, increasing disposable income, and availability of fertility treatments are also driving growth
• Based on provider, the fertility clinics segment held market with the largest revenue share of 80.02% in 2023, owing to the advancements in fertility clinics and the adoption of new technologies
• Europe dominated the market with the revenue share of 35.74% in 2023, due to increased investments from private equity investors in the European market, providing lucrative opportunities for market growth
• In May 2023, Genea Biomedx partnered with AIVF to offer an integrated solution for personalized and optimized IVF care
• In October 2022, the startup Alife launched AI technology to advance IVF treatment outcomes and lower costs

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Market Definitions
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources & Third-Party Perspectives
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Volume Price Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
  • 2.2.1. Type Outlook
  • 2.2.2. Provider Outlook
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
  • 3.3.2. Market Restraint Analysis
  • 3.3.3. Industry Opportunities
  • 3.3.4. Industry Challenges
• 3.4. Business Environment Analysis
  • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
• 3.5. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

• 4.1. Fertility Services Market: Type Movement Analysis
• 4.2. Fertility Services Type Market: Segment Dashboard
• 4.3. Type Movement & Market Share Analysis, 2023 & 2030
• 4.4. Global Fertility Services Market Estimates & Forecast, by Type
• 4.5. Diagnosis
  • 4.5.1. Diagnosis market, 2018 - 2030 (USD Million)
  • 4.5.2. Male infertility
    • 4.5.2.1. Male Infertility market, 2018 - 2030 (USD Million)
    • 4.5.2.2. DNA fragmentation technique
    • 4.5.2.2.1. DNA fragmentation technique market, 2018 - 2030 (USD Million)
    • 4.5.2.3. Oxidative stress analysis
    • 4.5.2.3.1. Oxidative stress analysis market, 2018 - 2030 (USD Million)
    • 4.5.2.4. Microscopic examination
    • 4.5.2.4.1. Microscopic examination market, 2018 - 2030 (USD Million)
    • 4.5.2.5. Sperm agglutination
    • 4.5.2.5.1. Sperm agglutination market, 2018 - 2030 (USD Million)
    • 4.5.2.6. Computer assisted semen analysis.
    • 4.5.2.6.1. Computer assisted semen analysis market, 2018 - 2030 (USD Million)
    • 4.5.2.7. Sperm penetration assay
    • 4.5.2.7.1. Sperm penetration assay market, 2018 - 2030 (USD Million)
    • 4.5.2.8. Others
    • 4.5.2.8.1. Others market, 2018 - 2030 (USD Million)
  • 4.5.3. Female infertility
    • 4.5.3.1. Female infertility market, 2018 - 2030 (USD Million)
    • 4.5.3.2. Ovarian reserve testing
    • 4.5.3.2.1. Ovarian reserve testing market, 2018 - 2030 (USD Million)
    • 4.5.3.3. Hysterosalpingography
    • 4.5.3.3.1. Hysterosalpingography market, 2018 - 2030 (USD Million)
    • 4.5.3.4. Hormone testing
    • 4.5.3.4.1. Hormone testing market, 2018 - 2030 (USD Million)
    • 4.5.3.5. Other tests
    • 4.5.3.5.1. Other tests market, 2018 - 2030 (USD Million)
• 4.6. Treatment
  • 4.6.1. Treatment market, 2018 - 2030 (USD Million)
  • 4.6.2. In-Vitro Fertilization (IVF)
    • 4.6.2.1. In-Vitro Fertilization (IVF) market, 2018 - 2030 (USD Million)
  • 4.6.3. Artificial insemination
    • 4.6.3.1. Artificial insemination market, 2018 - 2030 (USD Million)
• 4.7. Preservation
  • 4.7.1. Preservation market, 2018 - 2030 (USD Million)
  • 4.7.2. Egg & embryo freezing
    • 4.7.2.1. Egg & embryo freezing market, 2018 - 2030 (USD Million)
  • 4.7.3. Sperm banking
    • 4.7.3.1. Sperm banking market, 2018 - 2030 (USD Million)

Chapter 5. Provider Business Analysis

• 5.1. Fertility Services Market: Provider Movement Analysis
• 5.2. Fertility Services Provider Market: Segment Dashboard
• 5.3. Provider Movement & Market Share Analysis, 2023 & 2030
• 5.4. Global Fertility Services Market Estimates & Forecast, by Provider
• 5.5. Fertility Clinics
  • 5.5.1. Fertility clinics market, 2018 - 2030 (USD Million)
• 5.6. Hospitals and Others
  • 5.6.1. Hospitals and others market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

• 6.1. Regional Market Share Analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. North America Fertility Services Market, 2018 - 2030 (USD Billion)
  • 6.5.2. U.S.
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Reimbursement scenario
    • 6.5.2.4. Competitive scenario
    • 6.5.2.5. U.S. fertility services market, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Reimbursement scenario
    • 6.5.3.4. Competitive scenario
    • 6.5.3.5. Canada fertility services market, 2018 - 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Reimbursement scenario
    • 6.5.4.4. Competitive scenario
    • 6.5.4.5. Mexico fertility services market, 2018 - 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe Fertility Services Market, 2018 - 2030 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Reimbursement scenario
    • 6.6.2.4. Competitive scenario
    • 6.6.2.5. UK fertility services market, 2018 - 2030 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Reimbursement scenario
    • 6.6.3.4. Competitive scenario
    • 6.6.3.5. Germany fertility services market, 2018 - 2030 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Reimbursement scenario
    • 6.6.4.4. Competitive scenario
    • 6.6.4.5. France fertility services market, 2018 - 2030 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Reimbursement scenario
    • 6.6.5.4. Competitive scenario
    • 6.6.5.5. Italy fertility services market, 2018 - 2030 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Reimbursement scenario
    • 6.6.6.4. Competitive scenario
    • 6.6.6.5. Spain fertility services market, 2018 - 2030 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Reimbursement scenario
    • 6.6.7.4. Competitive scenario
    • 6.6.7.5. Sweden fertility services market, 2018 - 2030 (USD Million)
  • 6.6.8. Norway
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework
    • 6.6.8.3. Reimbursement scenario
    • 6.6.8.4. Competitive scenario
    • 6.6.8.5. Norway fertility services market, 2018 - 2030 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Key country dynamics
    • 6.6.9.2. Regulatory framework
    • 6.6.9.3. Reimbursement scenario
    • 6.6.9.4. Competitive scenario
    • 6.6.9.5. Denmark fertility services market, 2018 - 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific Fertility Services Market, 2018 - 2030 (USD Billion)
  • 6.7.2. Japan
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Reimbursement scenario
    • 6.7.2.4. Competitive scenario
    • 6.7.2.5. Japan fertility services market, 2018 - 2030 (USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Reimbursement scenario
    • 6.7.3.4. Competitive scenario
    • 6.7.3.5. China fertility services market, 2018 - 2030 (USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Reimbursement scenario
    • 6.7.4.4. Competitive scenario
    • 6.7.4.5. India fertility services market, 2018 - 2030 (USD Million)
  • 6.7.5. Australia
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Reimbursement scenario
    • 6.7.5.4. Competitive scenario
    • 6.7.5.5. Australia fertility services market, 2018 - 2030 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework
    • 6.7.6.3. Reimbursement scenario
    • 6.7.6.4. Competitive scenario
    • 6.7.6.5. Thailand fertility services market, 2018 - 2030 (USD Million)
  • 6.7.7. South Korea
    • 6.7.7.1. Key country dynamics
    • 6.7.7.2. Regulatory framework
    • 6.7.7.3. Reimbursement scenario
    • 6.7.7.4. Competitive scenario
    • 6.7.7.5. South Korea fertility services market, 2018 - 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America Fertility Services Market, 2018 - 2030 (USD Billion)
  • 6.8.2. Brazil
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Reimbursement scenario
    • 6.8.2.4. Competitive scenario
    • 6.8.2.5. Brazil fertility services market, 2018 - 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Reimbursement scenario
    • 6.8.3.4. Competitive scenario
    • 6.8.3.5. Argentina fertility services market, 2018 - 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. MEA Fertility Services Market, 2018 - 2030 (USD Billion)
  • 6.9.2. South Africa
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework
    • 6.9.2.3. Reimbursement scenario
    • 6.9.2.4. Competitive scenario
    • 6.9.2.5. South Africa fertility services market, 2018 - 2030 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework
    • 6.9.3.3. Reimbursement scenario
    • 6.9.3.4. Competitive scenario
    • 6.9.3.5. Saudi Arabia fertility services market, 2018 - 2030 (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework
    • 6.9.4.3. Reimbursement scenario
    • 6.9.4.4. Competitive scenario
    • 6.9.4.5. UAE fertility services market, 2018 - 2030 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key country dynamics
    • 6.9.5.2. Regulatory framework
    • 6.9.5.3. Reimbursement scenario
    • 6.9.5.4. Competitive scenario
    • 6.9.5.5. Kuwait fertility services market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Company Market Position Analysis
• 7.3. Strategy Mapping
  • 7.3.1. Expansion
  • 7.3.2. Acquisition
  • 7.3.3. Collaborations
  • 7.3.4. Others
• 7.4. Company Profiles/Listing
  • 7.4.1. PFCLA
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Service Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Mayo Foundation for Medical Education and Research (MFMER)
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Service Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. Cleveland Clinic
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Service Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Apricity Fertility UK Limited
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Service Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. King's Fertility Limited
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Service Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Dallas IVF
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Service Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Midwest Fertility Specialists
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Service Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. Europe IVF
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Service Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Care Fertility
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Service Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Aspire Fertility
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Service Benchmarking
    • 7.4.10.4. Strategic Initiatives
  • 7.4.11. Virtus Health
    • 7.4.11.1. Overview
    • 7.4.11.2. Financial Performance
    • 7.4.11.3. Service Benchmarking
    • 7.4.11.4. Strategic Initiatives
  • 7.4.12. Monash IVF Group
    • 7.4.12.1. Overview
    • 7.4.12.2. Financial Performance
    • 7.4.12.3. Service Benchmarking
    • 7.4.12.4. Strategic Initiatives